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The precision of axon targeting of mouse
olfactory sensory neurons requires the
BACE1 protease
Luxiang Cao, Gregory T. Rickenbacher, Steve Rodriguez, Thomas W. Moulia & Mark W. Albers
MassGeneral Institute of Neurodegenerative Disease, Dept. of Neurology, Harvard Medical School, Boston, MA 02129.
The b-site amyloid precursor protein cleaving enzyme 1 (BACE1) is necessary to generate the Ab peptide,
which is implicated in Alzheimer’s disease pathology. Studies show that the expression of BACE1 and its
proteaseactivity aretightlyregulated, butthephysiological functionofBACE1remainspoorlyunderstood.
Recently, numerous axon guidance proteins were identified as potential substrates of BACE1. Here, we
examined the consequences of loss of BACE1 function in a well-defined in vivo model system of axon
guidance,mouseolfactorysensoryneurons(OSNs).TheBACE1proteinresidespredominantlyinproximal
segmentand theterminiofOSNaxons, andthe expressionofBACE1inverselycorrelateswithodor-evoked
neural activity. The precision of targeting of OSN axons is disturbed in both BACE1 null and, surprisingly,
in BACE1 heterozygous mice. We propose that BACE1 cleavage of axon guidance proteins is essential to
maintain the connectivity of OSNs in vivo.
T
he intricate patterns of connectivity present in circuits in the mammalian nervous system provide a struc-
turalfoundationfornetworkactivitiesthatgovernbehavior
1.Cellsurfacemoleculesarearrayedonneurons,
astrocytes,andsupportingcellsintemporallyandspatiallyrestrictedprogramstoachievetheseconnectivity
patterns. By liberating domains of cell surface molecules, membrane bound proteases contribute to the complex,
dynamic environment necessary to guide axons to their intended targets in the developing nervous system and
maintain these circuits in the mature nervous system
2,3. The BACE1 protein is a type I transmembrane aspartic
protease that was discovered as the initial cleavage enzyme of the amyloid precursor protein to generate the Ab
peptide
4–8. Subsequent studies have identified other substrates of BACE1, but its physiologic function has not
been fully elucidated. The activity of the BACE1 gene product is tightly regulated by multiple levels of control:
transcriptional, splicing, translational, and posttranslational modifications, as well as intracellular trafficking
9.
BACE1 is expressed at high levels during development and in the early postnatal period in the central nervous
system, but its level of expression is significantly reduced in the adult nervous system
10. However, oxidative,
ischemic, and metabolic stresses lead to increased levels of BACE1 in adult neurons
11. Thus, BACE1 expression
corresponds with periods of structural plasticity of neural circuits. A recent proteomic study of substrates for
BACE1revealed68cellsurfacemoleculesaspossiblesubstrates
12.Manyoftheseproteinshaveadocumentedrole
in axon guidance and maintenance, e.g. semaphorins, EphA receptors, ephrins, and protocadherins. Moreover,
theBACE1cleavedectodomainofAPP,afterasecondcleavage,acceleratespruningofmotorneuronaxonsandof
retinal axons that target the superior colliculus during development
13.
To test the hypothesis that BACE1 plays an important role in axon function that underlies the structural
plasticity of neural circuits,we examined olfactory sensory neuron (OSNs) in mice that were either heterozygous
or null for the BACE1 gene. The peripheral olfactory neural circuit undergoes continuous structural plasticity
throughoutthelifetimeofthemouse
14–16.Intheperipheralolfactoryneuralcircuit,(OSN)axonsconvergetoform
a spatial map of olfactory receptor-evoked activity on the surface of the olfactory bulb
17. Primary olfactory
neurons express just one allele of one olfactory receptor gene from a family of over 1000 olfactory genes. To a
first approximation this choice is stochastic, so that patterns of activation on the surface of the olfactory epithe-
lium by a given odorant varies greatly between individual mice. However, the olfactory receptor protein also
instructs the projection of OSN axon termini to specific loci on the surface of the olfactory bulb, where they
synapsewithsecondorderolfactoryneuronsthatarededicatedtoonelocus.Thismapisfunctional;disruptionof
the projection pattern of OSNs erodes olfactory acuity in mice
18.
We find that the BACE1 protein is present predominantly in the proximal axons and distal axon termini of
mouse OSNs – locations of axon sorting and synaptogenesis, respectively, that are important for the establishment
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OSN axons from the olfactory epithelium to the olfactory bulb is
disturbed in both BACE1 heterozygous and BACE1 null mice during
their juvenile and adult stages of life. These results implicate an
important physiological role for BACE1 activity in the function of
axons in a neural circuit with documented plasticity.
Results
Expression of BACE1 in the mouse peripheral olfactory neural
circuit is activity dependent. Immunostaining of mouse olfactory
epithelial sections using an antibody against the BACE1 protein
revealed modest expression in the dendrites and soma of OSNs
(Fig. 1a). However, robust staining was seen in the axon bundles of
OSNs which costain with NCAM (Fig. 1c). In the mouse olfactory
bulb, the antibody recognizing BACE1 labelled the glomeruli in the
olfactory bulb (Fig. 1d), which is consistent with previous findings
in the rat olfactory bulb
19. Immunostaining of heterozygous or null
BACE1 mice
20 revealed labeling reduced about 50% (Fig. 1e) and
100% (Fig. 1f), respectively (Figure 1g). We examined BACE1
expression in primary olfactory neurons in the olfactory epit-
helium of mice using in situ hybridization. The level of expression
was present throughout the lamina, suggesting that both immature
and mature OSNs express BACE1 mRNA, with an slight increase in
mature OSNs (Fig. 1h). In addition, we observed a smooth gradient
of expression with the greatest levels of expression in the ventro-
lateral regions and the least expression in the dorsomedial regions.
In the olfactory bulb, we detected BACE1 mRNA in periglomerular
interneurons and second order olfactory neurons (mitral cells). No
signal was detected by probing with the sense strand (data not
shown).
Previous work in the rat olfactory bulb indicated an inverse rela-
tionship between the level of BACE1 protein and odor-evoked activ-
ity
19. Since BACE1 is regulated by transcriptional and translational
mechanisms, we determined whether naris closure alters BACE1
mRNA and proteins levels in wild type mice. Mice, who underwent
naris closure at P0, were analyzed at 2 weeks of age. BACE1 mRNA
wassubstantiallyincreasedinthedorsomedialregionoftheolfactory
epithelium(Fig. 1j) andolfactory bulb (Fig.1k) on theoccluded side,
thereby abrogating the gradient of expression. Moreover, BACE1
protein was increased in the glomeruli on the occluded side, particu-
larly in the dorsomedial glomeruli (Fig. 1l), paralleling the pattern of
changes of BACE1 mRNA expression in the olfactory epithelium.
Quantification of BACE1 protein expression in the glomeruli
revealed statistically significant differences in the dorsal, medial,
and lateral regions of the bulb (Fig. 1m). These olfactory bulb data
are consistent with the findings of increased BACE1 protein follow-
ing naris closure in the glomeruli of 7 to 8 month old mice that
overexpress a pathogenic APP allele
21.
BACE1proteinispresent intheproximal axonsandaxontermini
of OSNs. To localize the BACE1 protein in the glomeruli in the
olfactory bulb with subcellular resolution, we conducted multiple
costaining experiments with the specific markers of different cell
types that contribute to the neuropil within glomeruli. Specifically,
we costained with markers for axons (NCAM; Fig. 2a – d), OSNs
(OMP; Fig. 2e – h), interneurons (GAD65; Fig. 2i – l), dendrites of
second-order neurons (MAP2; Fig. 2m – p), postsynaptic densities
(PSD95; Fig. 2q – t) in the glomeruli. Each marker was compared
withtherelevantnon-glomerularlayer(ONLforaxonalmarkersand
EPL for dendritic markers). The olfactory marker protein (OMP) of
olfactory sensory axons exhibited a significant degree of overlap
with the BACE1 labeling pattern (Fig. 2h), as did the axonal marker
NCAM (Fig. 2d). By contrast, the dendrites of second order neurons
(MAP2; Fig 2m – o) exhibited an insignificant degree of overlap with
the BACE1 labeling pattern (Figure 2p). Overlap with the inter-
neuron marker (GAD65; Fig. 2l) was also significant in the glo-
merulus relative to the OPL. BACE1 immunostaining significantly
overlapped with staining of the postsynaptic marker (PSD95:
Fig. 2t). Taken together, these data indicate that BACE1 is ex-
pressed in the proximal (Fig. 1a) axon bundles and distal (Fig. 2)
axon termini of presynaptic OSNs near sites of synapses. Without
EM characterization, we cannot quantitatively determine the relative
proportions of BACE1 expression in primary, interneuron, and
second-order neuron post-synaptic compartments within a glo-
merulus, but our qualitative data suggests that BACE1 expression
is enriched in axonal compartments.
Axon mistargeting of OSNs in BACE1 heterozygous and BACE1
null mice in a dorsal to ventral gradient. We examined the
precision of OSN axon targeting in littermate BACE1 null, BACE1
heterozygous and wild type mice. The age ranges were from 1
to 3 months. To visualize OSN axon projection patterns, we
immunostained the olfactory bulbs with antibodies against the OR
M71. The convergence of OSN axons expressing the M71 OR was
disturbed in both BACE1 heterozygous and BACE1 null mice
(Figure 3a – d; p , 0.01). To determine whether BACE1 deficiency
influenced other subpopulations of OSNs, we crossed the BACE1
null mice with mice coexpressing GFP from one allele of the P2
olfactory receptor
22. Analysis of littermate wild type, BACE1
haploinsufficient, and BACE1 null mice showed a greater degree of
axon dispersion of P2-expressing OSNs in the BACE1 null mice
relative to the BACE1 heterozygous and wild type littermates
(Fig. 3e – h; p , 0.01). By contrast, analysis of the BACE1-
deficient mice crossed with a mouse line expressing a marker
protein coexpressed with the MOR28 olfactory receptor showed no
alteration in OSN axon targeting (Fig. 3i – 3l). These three olfactory
receptorsprojecttodifferentregionsoftheolfactorybulb,suggesting
a regional importance for the role of BACE1 in the precision of axon
targeting. In the dorsal olfactory bulb, M71-expressing OSNs exhibit
a significant difference between wild type and heterozygous BACE1
mice as well as heterozygous BACE1 and BACE1 null mice. For
P2-expressing OSNs in the equatorial bulb, BACE1 null mice are
significantly different from both BACE1 heterzygous and wild type
mice, but BACE1 heterozygous mice are not significantly different
from BACE1 null mice. The axons of ventral MOR28-expressing
OSNs targeted correctly.
Alterations in substrates in BACE1 deficient mice. APP and the
amyloidprecursorlikeprotein2(APLP2)arevalidatedsubstratesfor
BACE1 and are expressed by OSNs
9. APP is significantly increased
(Fig. 4d) in the glomeruli of the olfactory bulbs of both BACE1
heterozygous and BACE1 null mice as revealed by immuno-
staining with an antibody that recognizes the COOH-terminus
(Fig. 4a – c). A regional analysis of the olfactory bulb indicates
a significant increase in all quadrants of the BACE1 null mice.
Interestingly, the ventral and lateral regions are not significantly
(Fig. 4e) increased in the BACE1 heterozygous mice, which receive
OSN axons from ventral and lateral regions of theolfactory epithelium.
The ambient levels of BACE1 expression is greater in these regions,
a n dt h el e v e l sa r en o tm o d u l a t e db yo d o re v o k e da c t i v i t y( F i g .1 j ) .
Additionally, APLP2 levels are significantly increased (Fig. 4i) in the
outer nerve layer and glomeruli of the olfactory bulbs in both BACE1
heterozygous and BACE1 null mice (Fig. 4f–h) as revealed by an
antibody that recognizes the full length of APLP2. Similarly, all four
quadrants show a significant increase between BACE1 null and
littermate controls; however, onlyt h ev e n t r a lr e g i o nd o e sn o ts h o w
statistical significance between the BACE1 heterozygous mice and
littermate wild type controls (Fig. 4j). Together, these data indicate
that the BACE1 heterozygous mice are haploinsufficient, an
intriguing finding for an enzyme without known imprinting.
Reduced odor-evoked gene induction in BACE1 deficient mice.
To determine whether the OSN axon mistargeting in BACE1
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 231 | DOI: 10.1038/srep00231 2Figure 1 | BACE1expressioninmouseolfactoryepitheliumandolfactorybulbisactivitydependent. (a–c)BACE1immunoreactivity (IR)isenriched
in the axon bundles (arrows) of olfactory sensory neurons (OSNs), where it is colocalized with NCAM, an axon-specific marker protein. The insets
indicate that BACE1 is partially colocalized with NCAM in the axon bundles. (d) BACE1 IR is present in the olfactory bulb, with the highest level in the
glomerularlayer(GL),amodestlevelintheexternalplexiformlayer(EPL)andabsentinthemitralcelllayer(MCL).(e–f)BACE1IRisreducedinBACE1
heterozygous mice (BACE1 1/2) and absent in BACE1 homozygous knockout mice (BACE1 2/2). (g) Quantification of BACE1 IR intensity in the
olfactorybulb.(h–i)InsituhybridizationrevealsgradedlevelsofBACE1mRNAintheolfactoryepithelium(h)androbuststaininginthemitralcelllayer
of the olfactory bulb (i). Unilateral naris closure in control mice reveals a marked increase in the BACE1 mRNA levels on the closed side of the olfactory
epithelium(j)butnotinthemitralcellsoftheolfactorybulb(k).QuantitationoftheBACE1proteinlevelsintheglomerulioftheolfactorybulb(l)reveals
significant increases (m) in the dorsal, medial, and lateral regions of the olfactory bulb (p , 0.001). Black bars represent closed side, and gradient bars
represent the open side.
www.nature.com/scientificreports
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periglomerular neurons for tyrosine hydroxylase (TH). The levels
of expression of this gene is proportional to input from OSNs
23,24.
Immunostaining of the olfactory bulbs demonstrate reduced
induction of TH in BACE1 null but not BACE1 haploinsufficient
mice (Fig. 5), although a trend was present for the BACE1 hap-
loinsufficient mice. Consistent with the dorsal to ventral gradient
of axon mistargeting, we observe a dorsal to ventral loss of TH
induction in the olfactory bulb. This concordance supports the
notion that alterations in the fidelity of OSN axon targeting alter
perceived activity postsynaptically in BACE1-deficient mice. To
exclude the possibility that a loss of OSNs underlies the reduced
TH induction in BACE1 null mice, we quantified subpopulations
of OSNs defined by the olfactory receptors M71, P2, and MOR28.
No significant difference was observed in BACE1 null or BACE1
haploinsufficient mice relative to littermate controls (Fig. 6a – c).
Additionally, we did not find evidence of increased rate of neuro-
genesis in the olfactory epithelium as evidenced by expression of
BrdU labeling (Fig. 6d) or increased density of cleaved caspase 3
immunostaining (data not shown). Together these experiments
indicate that the connectivity disturbance is not a consequence of
accelerated turnover of OSNs in the olfactory epithelium.
Figure 2 | BACE1 IR predominantly colocalizes with pre-synaptic neuronal marker proteins in the mouse olfactory bulb. (a – c) Colocalization of
BACE1IRandNCAMIRinglomerularlayer(GL)butnotintheouternerverlayer(ONL).(d)PercentageofoverlappingpixelsofNCAMandBACE1in
GLandONL.(e–g)BACE1IRoverlapswithOMPIR,aspecificmarkerofOSNs,inGL.(h)PercentageofoverlappingpixelsofOMPandBACE1.(i–k)
BACE1 IR overlaps with GAD65 IR, a specific marker of inhibitory periglomerular cells in GL. (l) Percentage of overlapping pixels of of GAD65 and
BACE1 revealed that it is higher in GL than that in external plexiform layer (EPL). (m – o) Colocalization of BACE1 IR with MAP2 (a dendritic marker
protein)immunoreactivityinGLandOPL.(p)QuantificationoftheoverlappinglevelofMAP2andBACE1.(q–s)BACE1colocalizeswithpostsynaptic
protein PSD95 in GL and EPL. (t) Quantification of the overlapping level of PSD95 and BACE1. * 5 p , 0.05.
www.nature.com/scientificreports
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The emerging evidence supporting a role for membrane associated
proteases in axon guidance have focused on metalloproteases and c-
secretases in both invertebrate and vertebrate organisms
2,3. To test
the hypothesis that the membrane-associated protease BACE1 also
plays a role in guiding axons in vivo, we analyzed the connectivity of
OSNs in mice with only one or no BACE1 functional allele. The
expression of the BACE1 gene in the mouse olfactory epithelium is
graded with less BACE1 mRNA present in the dorsal and medial
regions.Thisdorsomedialareadoesnotconformtothestrictbound-
aries of zone 1
25,26. It is suggestive of regions of hydrophilic odor
absorption in the rat nose and may be related to neuronal activity
27.
Naris closure abrogates this gradient by increasing expression in the
medial and dorsal regions, providing additional evidence that odor-
evoked activity suppresses BACE1 gene expression
19.
Mouse OSNs are arranged in vivo with the soma and proximal
axons virtually bisected from the distal axons by the cribiform plate.
Employing this landmark we find that the BACE1 gene product
resides in the proximal segment of OSN axons and in distal axon
termini in the glomeruli. Moreover, axons of OSNs form an orderly,
reproducible projection pattern
17. This mapping of axons primarily
depends on the identity of the neurons, as defined by their choice of
olfactory receptor, and secondarily upon the spatial relationship of
their soma. We find that OSNs expressing the same olfactory recep-
tor do not project to the same glomerulus, which is consistent with
rolefortheBACE1proteaseinaxontargeting.Wecannotdistinguish
between the scenarios that the axons do interpret the cues en route
to their target with more errors or a deficit of pruning mistargeted
fibers. Indeed, a recent study that a BACE1-dependent cleavage
product of APP is involved in axon pruning in spinal cord neurons
and retinotectal projections
13. If this mechanism were operative, we
might expect evidence of diminished turnover of OSNs in the epi-
thelium of BACE1 deficient mice. However, the rates of neurogen-
esis, apoptosis, and steady state levels of olfactory receptor-defined
subpopulations are unchanged in BACE1 haploinsufficient or null
mice.
We favor the hypothesis that OSN axons are misinterpreting the
cues, perhaps by alterations of the levels of cell surface molecules
and/or modulating the production of physiological active cleavage
products. In BACE1 deficient mice we observed an increase (or
Figure 3 | Axon targeting of OSNs is altered in BACE1-deficient mice. (a) Immunostaining using an antibody against the OR M71 revealed that M71-
expressing OSN axon fibers converge to one specific glomerulus in each half bulb in wild type (BACE1 1/1) mice as indicated by the arrow. In BACE1
heterozygous (BACE1 1/2) mice (b) and BACE1 null mice (BACE1 2/2) (c), M71-expressing OSN axons project more glomeruli than one glomeruli
perhalfbulbasindicatedbythewhitearrowheads.(d)QuantificationofthenumberofglomerulireceivingM71projectionsperhalfbulbinBACE11/1,
BACE11/2andBACE12/2mice.DifferencesbetweenBACE11/2andBACE11/1,andbetweenBACE12/2andBACE11/1micearestatistically
significant.ImmunostainingusinganantibodyagainstGFPinP2-IRES-GFPtransgenicanimalscrossedtoBACE11/1mice(e),BACE11/2mice(f)or
BACE12/2mice(g)revealedadisturbanceofaxontargeting ofP2-expressing OSNsintheBACE1mutants.Quantification ofthenumber ofglomeruli
receivingP2OSNaxonprojectionsperhalfbulb(h)revealedstatisticallysignificantdifferencesbetweenBACE11/2andBACE11/1;andBACE12/2
andBACE11/1mice.Immunostaining usinganantibody againstMOR28revealedthattheaxonsofMOR28-expressing OSNsconvergetoonespecific
glomerulus in each half bulb of the BACE1 mutants (i – k). Quantification of the number of glomeruli receiving MOR28-expressing OSN axon
projectionsperhalfbulb(l)revealednostatisticallysignificantdifferencebetweenBACE11/2andBACE11/1,orBACE12/2andBACE11/1mice.
www.nature.com/scientificreports
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OSNs. Modulation of APP and APLP2 have been implicated in
neurite outgrowth
28, cortical neuron migration
29, and motor neuron
axon targeting
30. We have evidence that loss of function of APP
causes a disruption of the connectivity of the mouse peripheral
olfactory neural circuit (L.C, G.T.R., S.R., T.W.M., M.W.A., in pre-
paration). Several proposed substrates for BACE1, e.g., ephrin-A5
and protocadherins, are cell surface molecules with defined roles in
axon guidance of mouse olfactory sensory neurons
31,32. We also
observe increased levels of ephrin expression, as evidenced by
EphA4 ectodomain binding revealed by alkaline phosphatase stain
(data not shown)
32. Elegant genetic studies have demonstrated the
Figure 4 | Increased presence of APP and APLP2 in olfactory bulbs of BACE1 heterozygous and null mice. Representative images of immunostaining for
APP in olfactory bulbs from littermate wild type (a), BACE1 1/2 (b), and BACE1 2/2 (c). Quantification of the intensity of immunostaining (d) revealed a
significant difference between the BACE1 2/2 with either the wild type or BACE 1 1/2 mice (n 5 3 sets of 3 littermates). A regional analysis of immuno-
staining (e) in the glomeruli of the olfactory bulb reveals significant increases in APP staining in the ventral and lateral regions. Representative images of
immunostaining for APLP2 in olfactory bulbs from littermate wild type (f), BACE1 1/2(g), and BACE1 2/2(h). Quantification of the intensity of immuno-
staining (i) revealed a significant difference between the BACE1 2/2 with either the wild type or BACE 1 1/2 mice (n 5 3 sets of 3 littermates). A regional
analysisof immunostaining (j)in theglomeruli of the olfactorybulb reveals significantincreases in APLP2 staining inall 4 regions.*5p,0.05; ** 5p,0.01.
Figure 5 | Reduced tyrosine hydroxylase induction in BACE1 null mice.
Tyrosinehydroxylase(TH)levelscorrelatewithOSNinputintoglomeruli.
Representativeimagesofolfactorybulbsimmunostainedwithanantibody
recognizing TH (red) and a nuclear stain DAPI (blue) from a control
BACE1 1/1 mouse (a), a BACE1 1/2 mouse (b), and a BACE1 2/2
mouse (c). Quantitation of the intensity of TH staining in glomeruli of
BACE1deficientmice(n54)andwildtypelittermatemice(n54)reveals
a statistically significant difference (p , 0.05) between BACE1 1/1 and
BACE1 2/2 mice (d).
Figure 6 | Nosignificant loss of specific OSN populations or altered rates
of neurogenesis in BACE1 null and heterozygous mice. Normalized
counts ofgenetically defined subpopulations of M71- (a), MOR28- (b), or
P2- (c) expressing OSNs in a systematic series of sections spanning the
entire olfactory epithelium are not significantly different (p . 0.05,
mutants vs. control, n 5 4). (d) Quantitation of the normalized density of
BrdU-positive OSNs in a series of sections spanning the entire olfactory
epithelium in BACE1 2/2, BACE1 1/2 and wild type control mice
reveals no significant difference (p . 0.05, mutants vs. control, n 5 4).
www.nature.com/scientificreports
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bers are candidate BACE1 substrates)
12, in the establishment of the
map of OSN axon projections
33,34,35.Specifically, neuropilin-1 and its
ligand semaphorin 3A mediate axon sorting in the proximal OSN
axon bundles
36, a site of high BACE1 expression.
Bothgeneticandbiochemicalevidenceimplicatethegenerationof
the Aß peptide as playing a central role in the pathogenesis of early-
onset Alzheimer’s disease (AD)
37,38. Mice with deletions of the
BACE1 gene do not produce Aß when they are crossed with mice
overexpressing human APP in the brain
39. The amyloid pathology,
memory deficits, cholinergic dysfunction in the hippocampus, and
neuronal loss seen in the 5x-FAD line, which overexpress human
APP and presenilin 1 proteins with several pathogenic mutations,
were absent in 5xFAD mice on a BACE1 null background
40. Thus,
BACE1 is essential for Aß production in mice, and inhibitors of
BACE1 are under development as potential therapeutic targets in
humans.
OneimplicationofthisstudyisthatmoleculesthatinhibitBACE1
function may have the undesired side effect of altering neural con-
nections in brain regions with structural plasticity. BACE1 null mice
exhibit alterations in long term potentiation as well as memory and
emotional behavioral tasks, all of which depend on structural plas-
ticity of neural circuits
20. One uncommon feature of the olfactory
neural circuit is ongoing neurogenesis throughout the life of the
organism. However, continuous neurogenesis is also a feature of
the dentate gyrus of the hippocampus. It is difficult to assess the
precision of connectivity in the dentate gyrus since cell-type specific
markers that define the projection target are not yet available.
Nevertheless, it remains possible that axon mistargeting in the hip-
pocampal neural circuit accounts in part for the learning and elec-
trophysiological deficits documented in BACE1 null animals
20.I n
addition, BACE1 is also upregulated after neuronal injury from
ischemic or traumatic insults
41. Inhibition of BACE1 function may
hamper the repair or recovery process by altering the plasticity res-
ponses to these insults. Our results demonstrating connectivity phe-
notypes in a neural circuit with defined plasticity in the BACE1
haploinsufficient mouse raise an element of caution about the thera-
peutic strategy to partially inhibit BACE1, and provide impetus for
the development of substrate-specific BACE1 modulators. Future
studies employing directed recombination to abrogate BACE1 ex-
pression in restricted populations of neurons will elucidate its func-
tion with finer resolution in the context of neural circuits in vivo.
In summary, genetic reduction or elimination of the BACE1 pro-
tein results in alterations in structural connectivity of the mouse
peripheralolfactoryneuralcircuit.Recentstudiesrevealedthatorder
emerges in the axon bundles of OSNs by precise sorting to form
fascicles that generate the spatial projection map in the olfactory
bulb
33. Our data are consistent with a model that BACE1 regulates
the spatial and temporal code of cell surface molecules that afford
identity-driven sorting of axon fascicles and their targeting. Future
studies will be directed at identifying the BACE1 substrates that
mediate OSN axon sorting and the precise role of BACE1 cleavage
ofthesesubstrates,e.g.downregulationofcellsurfacemoleculesand/
or unleashing biologically active fragments. More generally, recent
studies have suggested additional roles for axon guidance molecules
in the mature nervous system, such as axon pruning and cell death
42.
Further studies will be focused on defining the role that BACE1
function plays, if any, in orchestrating these processes.
Methods
Animals. All experiments were in accordance with protocols approved by the
Institutional Animal Care and Use Committee of Massachusetts General Hospital.
BACE1 null
43 were obtained from Jackson Labs (Bar Harbor, ME). P2-ires-GFP
22
mice were a gift from Richard Axel (Columbia University). Naris closure was
performed on P0 mice as previously described
44. To generate tissue blocks for
sectioning, the mice were anesthetized with an intraperitoneal injection of 3,3,
3-tribromoethanol (1.25% in PBS 30 mL/g body weight). Following thoracotomy,
intracardiac perfusion with 10 mL of PBS (pH 7.4) was performed.
In situ hybridization. Twenty mm thick fresh frozen tissue sections were placed on
Superfrost slides (Fisher Scientific). The sections were dried for 45 min. at room
temperature before fixing with 4% paraformaldehyde for 15 min., and washed three
times in 1x DEPC-treated PBS containing 1 mM MgCl2. Slides were then immersed
in a solution containing 270 mL of DEPC treated water, 30 mL of 1 M
triethanolamine and 750 mL of 95% acetic anhydride for 10 minutes, and
subsequently washed 3x in 1x DEPC-treated PBS containing 1 mM MgCl2.Slides
were then blocked for 2 hours with hyridization buffer: 0.1% Tween20, 50%
formamide, 5x SSC, 5x Denhardts, 5 mM EDTA, 10 mM NaH2PO4 at pH. 8.0, 50 mM
Tris pH 8.0, 250 mg/mL salmon sperm DNA, 100 mgram/mL tRNA, 100 mg/mL
yeast RNA. Slides were dabbed dry and RNA probes (100 mg/mL), preheated for
5 min. at 80uC and cooled on ice for 2 min., and were applied to the slides. The slides
were sealed in a humidified chamber and incubated at 65uC overnight. After 18 h the
slides were washed three times in 5xSSC at 65uC for 15 min., and then three times
with 0.2x SSC for 20 min. After blocking in 1x in situ hybridization blocking solution
(Roche) for 1 h, the slides were dabbed dry and a sheep antibody recognizing
digoxetin (153000, Roche) was applied overnight. The next day the RNA probe was
detected using the HNPP fluorescent detection kit (Roche) or BCIP/NBT (Promega).
Immunohistochemistry. For immunostaining using antibodies against the olfactory
receptors (ORs) MOR28 and M71, the sections were post-fixed with 1%
paraformaldehyde in PBS for 8 min. at room temperature. For the other antibodies,
themiceweresubsequentlyperfusedwith4%paraformaldehydeinPBS(pH7.4).The
olfactory turbinates and olfactory bulbs were dissected intact, incubated in 30%
sucroseinPBSat4uCovernight,andembeddedinOCT(Sakura)orM1(Shandon)in
a dry ice/ethanol bath. Twenty mm coronal sections were cut on a cryostat (Microm)
and collected on SuperFrost slides (Fisher). All sections were washed three times in
PBSfor10 min.,permeabilizedin0.1%TritonX-100inPBS(PT)for30 min.atroom
temperature,blockedin5%heat-inactivatedhorseseruminPT(PTS)for1 hatroom
temperature, incubated withprimaryantibodyinPTSunderaHybrislip(Invitrogen)
overnight in a humidified chamber at 4uC, washed three times with PT for 10 min.,
blocked with PTS for 30 min. at room temperature, incubated with a fluorescent-
conjugated secondary antibody in PTS with TOTO-3 (Invitrogen, 151000) or DAPI
(Invitrogen 100 ng/mL) for 2 h at room temperature, washed briefly in PBS, and
Vectashield was applied to each slide and coverslipped. Slides were imaged using a
Zeiss LSM-510 confocal microscope, or a Zeiss inverted fluorescent microscope and
analyzed using ImageJ (NIH).
Primary antibodies included rabbit anti-BACE1 (Cell Signaling, 15500), rabbit
anti-GFP (Molecular Probes; 151000), sheep anti-GFP (Biogenesis; 151000), rabbit
anti-LacZ (Cappel; 151000), rabbit anti-MOR28 (153000) (Barnea et al., 2004),
guinea pig anti-M71 (151000) (Barnea et al., 2004), rabbit anti-APLP2 (Calbiochem;
15500), rabbit anti-APP (Zymed; 15300), rabbit anti-activated caspase 3 (Cell
Signaling; 15500), mouse anti-BrdU (Invitrogen; 151000), mouse anti-reelin
(Developmental Studies Hybridoma Bank of University of Iowa; 1510), mouse anti-
tyrosine hydroxylase (Millipore; 15500), mouse anti-PSD95 (Neuromap; 15200),
mouse anti-NCAM (Sigma; 15300), goat anti-OMP (Wako; 15500), mouse anti-
GAD65 (BD; 15100), and mouse anti-MAP2 (Sigma, 15100). Secondary antibodies
were Alexa 488-conjugated or Cy3-conjugated donkey anti-rabbit IgG (Molecular
Probes; 15500), Alexa488-conjugated donkey anti-sheep IgG (Molecular Probes;
15500), Cy3-conjugated donkey anti-guinea pig IgG (Jackson Immunoresearch;
15500), Alexa 488-conjugated or Cy3-conjugated donkey anti-mouse IgG (Jackson
Immunoresearch; 15500) and Cy3-conjugated donkey anti-rabbit IgG (Jackson
Immunoresearch; 15500).
Statistical Analyses. One-way analysis of variance and unpaired t-tests were used,
as appropriate. Each statistical test was performed as described in the methods and
figures legends using Excel (Microsoft), or Numbers (Apple).
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